PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
J Immunother Cancer. 2020 May;8(1):e000450. doi: 10.1136/jitc-2019-000450.
J Immunother Cancer. 2020.
PMID: 32439799
Free PMC article.